Related Experiment Video
Updated: Jan 30, 2026

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?
Michael J Birrer1, Ilaria Betella2, Lainie P Martin3
1O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA mbirrer@uab.edu.
Abstract:
Prognosis for women with epithelial ovarian cancer remains poor. One new molecular target in epithelial ovarian cancer is folate receptor alpha (FRα). This commentary discusses the characteristics that contribute to its attractiveness as a candidate for therapeutic intervention.
Insights
Prognosis for epithelial ovarian cancer is poor, but folate receptor alpha (FRα) presents a promising molecular target. This commentary explores FRα's characteristics making it an attractive option for new cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Epithelial ovarian cancer (EOC) has a historically poor patient prognosis.
- There is an ongoing need for novel therapeutic targets in EOC.
- Folate receptor alpha (FRα) has emerged as a potential molecular target.
Purpose of the Study:
- To discuss the characteristics of folate receptor alpha (FRα).
- To evaluate FRα as a potential therapeutic target in epithelial ovarian cancer.
- To highlight the attractiveness of FRα for drug development.
Main Methods:
- This is a commentary, not an experimental study.
- Literature review and analysis of FRα properties.
- Discussion of biological and clinical relevance of FRα.
Main Results:
- FRα is overexpressed in a significant subset of epithelial ovarian cancers.
- FRα's cell surface localization and internalization mechanisms are favorable for targeted delivery.
- Its differential expression compared to normal tissues suggests potential for selective toxicity.
Conclusions:
- Folate receptor alpha (FRα) possesses key characteristics making it a highly attractive target for therapeutic intervention in epithelial ovarian cancer.
- Targeting FRα may offer a new strategy to improve outcomes for women with this disease.
- Further research and development of FRα-targeted therapies are warranted.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Internal Receptors
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Ovarian Cycle
The Effect of Aging on Tissues
Receptor-mediated Endocytosis

